A Multicenter, Randomized, Double-blind, Placebo-parallel, Phase II Clinical Trial of the Efficacy and Safety of Anfibatide in Treating Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Anfibatide (Primary)
- Indications Thrombotic thrombocytopenic purpura
- Focus Therapeutic Use
- Sponsors Lee's Pharmaceutical
Most Recent Events
- 17 Jul 2019 New trial record